Equities

GSK plc

GSK:LSE

GSK plc

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)1,392.50
  • Today's Change-14.50 / -1.03%
  • Shares traded15.72m
  • 1 Year change-4.45%
  • Beta0.5967
Data delayed at least 20 minutes, as of Oct 31 2024 16:08 BST.
More ▼

IC View

The last IC recommendation on GSK plc shares was Buy at 1.00 on 09 May 2024Read the full article

Key statistics

On Thursday, GSK plc (GSK:LSE) closed at 1,392.50, 1.54% above its 52-week low of 1,371.40, set on Nov 16, 2023.
52-week range
Today
1,371.40Nov 16 20231,823.50May 16 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open1,396.50
High1,401.50
Low1,373.00
Bid1,371.00
Offer1,452.00
Previous close1,407.00
Average volume9.06m
Shares outstanding4.15bn
Free float4.08bn
P/E (TTM)14.36
Market cap58.32bn GBP
EPS (TTM)0.9796 GBP
Annual div (ADY)61.00 GBX
Annual div yield (ADY)4.34%
Div ex-dateAug 15 2024
Div pay-dateOct 10 2024
Next div ex-dateNov 14 2024
Next div pay-dateJan 09 2025
Data delayed at least 20 minutes, as of Oct 31 2024 16:08 BST.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.